TY - JOUR
T1 - Costs and cost-effectiveness of the meeting centres support programme for people living with dementia and carers in Italy, Poland and the UK
T2 - The MEETINGDEM study
AU - Henderson, Catherine
AU - Rehill, Amritpal
AU - Brooker, Dawn
AU - Evans, Simon C.
AU - Evans, Shirley B.
AU - Bray, Jennifer
AU - Saibene, Francesca Lea
AU - Scorolli, Claudia
AU - Szcześniak, Dorota
AU - d’Arma, Alessia
AU - Lion, Katarzyna
AU - Atkinson, Teresa
AU - Farina, Elisabetta
AU - Rymaszewska, Joanna
AU - Chattat, Rabih
AU - Meiland, Franka
AU - Dröes, Rose-Marie
AU - Knapp, Martin
N1 - Funding Information: This was an EU Joint Programme – Neurodegenerative Disease Research (JPND) Project, Grant/Award Number HC‐559‐018. The work was supported through the following funding organisations under the aegis of JPND: Italy, Ministry of Education and Ministry of Health; the Netherlands, ZonMw; Poland, Narodowe Centrum Badań i Rozwoju; and UK, Economic and Social Research Council, Grant/Award Number: ES/L00920X/1. Funding Information: MEETINGDEM (2014-17) is an EU Joint Programme ? Neurodegenerative Disease Research JPND_HC-559-018. The project is supported through the following funding organisations under the aegis of JPND: Italy, Ministry of Education and Ministry of Health; The Netherlands, ZonMw; Poland, NCBR; UK, ESRC Grant reference: ES/L00920X/1. This was an EU Joint Programme ? Neurodegenerative Disease Research (JPND) Project, Grant/Award Number HC-559-018. The work was supported through the following funding organisations under the aegis of JPND: Italy, Ministry of Education and Ministry of Health; the Netherlands, ZonMw; Poland, Narodowe Centrum Bada? i Rozwoju; and UK, Economic and Social Research Council, Grant/Award Number: ES/L00920X/1. Funding Information: MEETINGDEM (2014‐17) is an EU Joint Programme – Neurodegenerative Disease Research JPND_HC‐559‐018. The project is supported through the following funding organisations under the aegis of JPND: Italy, Ministry of Education and Ministry of Health; The Netherlands, ZonMw; Poland, NCBR; UK, ESRC Grant reference: ES/L00920X/1. Publisher Copyright: © 2021 John Wiley & Sons Ltd.
PY - 2021/11
Y1 - 2021/11
N2 - We examined the costs and cost-effectiveness of the Meeting Centre Support Programme (MCSP) implemented and piloted in the UK, Poland and Italy, replicating the Dutch Meeting Centre model. Dutch Meeting Centres combine day services for people with dementia with carer support. Data were collected over 2015–2016 from MCSP and usual care (UC) participants (people with dementia-carer dyads) at baseline and 6 months. We examined participants’ health and social care (HSC), and societal costs, including Meeting Centre (MC) attendances. Costs and outcomes in MCSP and UC groups were compared. Primary outcomes: Persons with dementia: quality-adjusted life years (EQ-5D-5L-derived); QOL-AD. DQoL was examined as a secondary outcome. Carers: Short Sense of Competence Questionnaire (SSCQ). Incremental cost-effectiveness ratios (ICER) and cost-effectiveness acceptability curves were obtained by bootstrapping outcome and cost regression estimates. Eighty-three MCSP and 69 UC dyads were analysed. The 6-month cost of providing MCSP was €4,703; participants with dementia attended MC a mean of 45 times and carers 15 times. Including intervention costs, adjusted 6-month HSC costs were €5,941higher in MCSP than in UC. From the HSC perspective: in terms of QALY, the probability of cost-effectiveness was zero over willingness-to-pay (WTP) ranging from €0 to €350,000. On QOL-AD, the probability of cost-effectiveness of MCSP was 50% at WTP of €5,000 for a one-point increase. A one-point gain in the DQoL positive affect subscale had a probability of cost-effectiveness of 99% at WTP over €8,000. On SSCQ, no significant difference was found between MCSP and UC. Evidence for cost-effectiveness of MCSP was mixed but suggests that it may be cost-effective in relation to gains in dementia-specific quality of life measures. MCs offer effective tailored post-diagnostic support services to both people with dementia and carers in a context where few evidence-based alternatives to formal home-based social services may be available.
AB - We examined the costs and cost-effectiveness of the Meeting Centre Support Programme (MCSP) implemented and piloted in the UK, Poland and Italy, replicating the Dutch Meeting Centre model. Dutch Meeting Centres combine day services for people with dementia with carer support. Data were collected over 2015–2016 from MCSP and usual care (UC) participants (people with dementia-carer dyads) at baseline and 6 months. We examined participants’ health and social care (HSC), and societal costs, including Meeting Centre (MC) attendances. Costs and outcomes in MCSP and UC groups were compared. Primary outcomes: Persons with dementia: quality-adjusted life years (EQ-5D-5L-derived); QOL-AD. DQoL was examined as a secondary outcome. Carers: Short Sense of Competence Questionnaire (SSCQ). Incremental cost-effectiveness ratios (ICER) and cost-effectiveness acceptability curves were obtained by bootstrapping outcome and cost regression estimates. Eighty-three MCSP and 69 UC dyads were analysed. The 6-month cost of providing MCSP was €4,703; participants with dementia attended MC a mean of 45 times and carers 15 times. Including intervention costs, adjusted 6-month HSC costs were €5,941higher in MCSP than in UC. From the HSC perspective: in terms of QALY, the probability of cost-effectiveness was zero over willingness-to-pay (WTP) ranging from €0 to €350,000. On QOL-AD, the probability of cost-effectiveness of MCSP was 50% at WTP of €5,000 for a one-point increase. A one-point gain in the DQoL positive affect subscale had a probability of cost-effectiveness of 99% at WTP over €8,000. On SSCQ, no significant difference was found between MCSP and UC. Evidence for cost-effectiveness of MCSP was mixed but suggests that it may be cost-effective in relation to gains in dementia-specific quality of life measures. MCs offer effective tailored post-diagnostic support services to both people with dementia and carers in a context where few evidence-based alternatives to formal home-based social services may be available.
KW - cost-effectiveness
KW - dementia and cognitive disorders
KW - post-diagnostic support
KW - psychosocial interventions
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85099755274&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/33506538
U2 - https://doi.org/10.1111/hsc.13281
DO - https://doi.org/10.1111/hsc.13281
M3 - Article
C2 - 33506538
SN - 0966-0410
VL - 29
SP - 1756
EP - 1768
JO - Health and Social Care in the Community
JF - Health and Social Care in the Community
IS - 6
ER -